Skip to main content
logo
Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
15.28
+0.20 (1.33%)
Jul 10, 2026, 9:59 AM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Biologic Therapies for Autoimmune and Allergic Diseases
806.96M158.79M-9.66M21.35M
Biologic Therapies for Autoimmune and Allergic Diseases Growth
408.18%---54.74%-
Total
806.96M158.79M-9.66M21.35M
Total Growth
408.18%---54.74%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
The People's Republic of China (The "PRC")
104.56M158.79M-9.66M21.35M
The People's Republic of China (The "PRC") Growth
-34.15%---54.74%-
The United States
197.80M----
Switzerland
504.60M----
Total
806.96M158.79M-9.66M21.35M
Total Growth
408.18%---54.74%-